Evidence map›Paper›PMID 25939039›Full record

ArticleInflammatory bowel diseases2015

Colonic Insult Impairs Lymph Flow, Increases Cellular Content of the Lymph, Alters Local Lymphatic Microenvironment, and Leads to Sustained Inflammation in the Rat Ileum.

Walter Cromer, Wei Wang, Scott D Zawieja, Pierre-Yves von der Weid, M Karen Newell-Rogers, David C Zawieja

Open access · bronzeAbstract read
In one paragraph

Article in Inflammatory bowel diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
8.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. The role of lymphatics in intestinal inflammation.Inflammation and regeneration · 2021
    Review
  11. Review
  12. Review
  13. Article
  14. Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  15. Article
  16. Differences in L-type CaAmerican journal of physiology. Heart and circulatory physiology · 2018
    Article
  17. Burn Injury-Associated MHCIILymphatic research and biology · 2018
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Walter Cromer*Division of Lymphatic Biology, Department of Medical Physiology, Texas A&M University Health Science Center College of Medicine, Temple, Texas; †Department of Physiology and Pharmacology, Inflammation Research Network, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, AB, Canada; and ‡Department of Surgery, Center for Cell Death and Differentiation, Texas A&M University Health Science Center College of Medicine, Temple, Texas.
Wei Wang
Scott D Zawieja
Pierre-Yves von der Weid
M Karen Newell-Rogers
David C Zawieja
Texas A&M University · USTexas A&M Health Science Center · USUniversity of Calgary · CA

Funding

Lymphatic Fluid Flow Modeling with Active Network ComponentsR01HL094269 · NHLBI · TEXAS ENGINEERING EXPERIMENT STATION · PI KAUNAS, ROLAND RAYMOND · 2009 to 2012
$2.7M
Influences of Lymph Flow on the Lymphatic PumpR01HL070308 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ZAWIEJA, DAVID CARL · 2003 to 2010
$2.4M
Ionic Mechanisms of Stretch-Activation in Muscular LymphaticsR01HL096552 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI VON DER WEID, PIERRE-YVES, ZAWIEJA, DAVID CARL · 2009 to 2012
$1.7M
Role of mesenteric lymphatics and dietary endotoxin in metabolic syndromeR01DK099221 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MUTHUCHAMY, MARIAPPAN, ZAWIEJA, DAVID CARL · 2013 to 2015
$976k
NCI NIH HHS CA136466NHLBI NIH HHS HL096552NHLBI NIH HHS R01 HL070308NHLBI NIH HHS R01 HL094269NHLBI NIH HHS R01 HL096552NIDDK NIH HHS DK099221NIDDK NIH HHS R01 DK099221
6 · The paper itself

Abstract

backgroundLymphatic dysfunction has been linked to inflammation since the 1930s. Lymphatic function in the gut and mesentery is grossly underexplored in models of inflammatory bowel disease despite the use of lymphatic occlusion in early models of inflammatory bowel disease. Activation of the innate and adaptive immune system is a hallmark of TNBS-induced inflammation and is linked to disruption of the intrinsic lymph pump. Recent identification of crosstalk between lymphatic vessel resident immune cells and regulation of lymphatic vessel contractility underscore the importance of the timing of lymphatic dysfunction during tissue inflammation in response to TNBS.

methodsTo evaluate lymphatic function in TNBS induced inflammation, lymph was collected and flow measured from mesenteric lymphatics. Cellularity and cytokine profile of the lymph was also measured. Histopathology was performed to determine severity of injury and immunofluorescent staining of the mesentery was done to evaluate changes in the population of immune cells that reside near and on gastro-intestinal collecting lymphatics.

resultsLymph transport fell 24 hours after TNBS administration and began recovering at 72 hours. Significant reduction of lymph flow preceded significant increase in histopathological score and occurred simultaneously with increased myeloperoxidase activity. These changes were preceded by increased MHCII cells surrounding mesenteric lymphatics leading to an altered lymphatic environment that would favor dysfunction.

conclusionsAlterations in environmental factors that effect lymphatic function occur before the development of gross GI inflammation. Reduced lymphatic function in TNBS-mediated inflammation is likely an early factor in the development of injury and that recovery of function is associated with resolution of inflammation.

Indexed as

Immunity, CellularAnimalsColonDendritic CellsDisease Models, AnimalIleitisIleumImmunohistochemistryIschemiaLymphatic VesselsRats

Identifiers

PMID25939039
PMCPMC4466086
OpenAlexW2326397357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.